<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; MAXIMUS Inc.</title>
	<atom:link href="http://www.stockbloghub.com/tag/maximus-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(AAPL) Company News for September 28, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/10/03/aapl-company-news-for-september-28-2011-corporate-summary/84202</link>
		<comments>http://www.stockbloghub.com/2011/10/03/aapl-company-news-for-september-28-2011-corporate-summary/84202#comments</comments>
		<pubDate>Mon, 03 Oct 2011 19:20:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[Aruba Networks Inc.]]></category>
		<category><![CDATA[ARUN]]></category>
		<category><![CDATA[BG]]></category>
		<category><![CDATA[Bunge Limited]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Flotek Industries Inc]]></category>
		<category><![CDATA[ftk]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>
		<category><![CDATA[Motorola Solutions]]></category>
		<category><![CDATA[MSI]]></category>
		<category><![CDATA[Research In Motion Limited]]></category>
		<category><![CDATA[RIMM]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84202</guid>
		<description><![CDATA[•    Rumors did the rounds that billionaire investor Carl Icahn might purchase a stake in Research In Motion Limited (NASDAQ:RIMM) •    According to reports, Apple Inc. (NASDAQ:AAPL) is expected to launch its latest iPhone on next Tuesday •    Walgreen Co. (NYSE:WAG) was one of the heaviest losers in the S&#38;P 500 after it said that talks with Express Scripts Inc. (NASDAQ:ESRX) to renew a contract for providing prescriptions to the latter’s customers had failed •    U.S. regulatory authorities are investigating Motorola Solutions, Inc. (NYSE:MSI) to ascertain whether it paid bribes to gain business in Europe •    Flotek Industries Inc. (NYSE:FTK) said its revenues increased from $23 million in July to $25 million in August •    Jefferies initiated coverage on Aruba Networks, Inc. (NASDAQ:ARUN) with a “Hold” rating •    Citigroup, Inc. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/03/aapl-company-news-for-september-28-2011-corporate-summary/84202/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HSP) Hospira Earnings Beat The Street &#8211; Backs Outlook</title>
		<link>http://www.stockbloghub.com/2011/05/03/hsp-hospira-earnings-beat-the-street-backs-outlook/72495</link>
		<comments>http://www.stockbloghub.com/2011/05/03/hsp-hospira-earnings-beat-the-street-backs-outlook/72495#comments</comments>
		<pubDate>Tue, 03 May 2011 19:27:19 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[APAC]]></category>
		<category><![CDATA[APAC Customer Services Inc]]></category>
		<category><![CDATA[Eli Lilly & Company]]></category>
		<category><![CDATA[Hospira Inc.]]></category>
		<category><![CDATA[HSP]]></category>
		<category><![CDATA[LLY]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>
		<category><![CDATA[Sanofi-Aventis]]></category>
		<category><![CDATA[SNY]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=72495</guid>
		<description><![CDATA[Hospira Inc. (HSP) reported earnings per share of 93 cents for the first quarter of 2011, well above the Zacks Consensus Estimate of 79 cents. Earnings benefited from strong US sales of the generic version of Sanofi Aventis’ (SNY) cancer drug Taxotere which was launched in March 2011. Results were however 1 cent below the year-earlier earnings of 94 cents due to difficult year-over-year comparisons. Earnings in the prior-year quarter were boosted by strong margin contribution from US sales of Hospira’s generic version of Sanofi’s Eloxatin (oxaliplatin) which has been temporarily discontinued. Higher research and development expenses also affected earnings in the quarter. First quarter revenues of $1 billion were almost flat year over year. Total revenues beat the Zacks Consensus Estimate of $941 million. The top line was boosted ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/03/hsp-hospira-earnings-beat-the-street-backs-outlook/72495/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HSP) Hospira Second Quarter 2010 Earnings Preview</title>
		<link>http://www.stockbloghub.com/2010/08/02/hsp-hospira-second-quarter-2010-earnings-preview/44895</link>
		<comments>http://www.stockbloghub.com/2010/08/02/hsp-hospira-second-quarter-2010-earnings-preview/44895#comments</comments>
		<pubDate>Mon, 02 Aug 2010 21:52:31 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BAX]]></category>
		<category><![CDATA[Baxter International Inc]]></category>
		<category><![CDATA[Carefusion Corporation]]></category>
		<category><![CDATA[CFN]]></category>
		<category><![CDATA[DRRX]]></category>
		<category><![CDATA[Durect Corporation]]></category>
		<category><![CDATA[GENZ]]></category>
		<category><![CDATA[Genzyme Corporation]]></category>
		<category><![CDATA[Hospira Inc.]]></category>
		<category><![CDATA[HSP]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=44895</guid>
		<description><![CDATA[Hospira Inc. (HSP) is scheduled to report its second quarter 2010 results on Wednesday, July 28, before the opening bell. The Zacks Consensus Estimate for the quarter is earnings of 79 cents per share (with an upside of 2.53%), compared with earnings of 73 cents per share in the year-earlier period. The Zacks Consensus Estimate for second-quarter revenue is $1,006 million as against $957 million reported in the year-ago quarter. First-Quarter Recap Hospira Inc.’s first-quarter fiscal 2010 earnings (excluding special items) of 94 cents per share handsomely beat the Zacks Consensus Estimate of 72 cents and the year-ago earnings of 60 cents. On a reported basis, the company earned 84 cents per share, down 18.4% from the year-ago earnings. Revenues for the quarter climbed 17.2% year over year to $1 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/02/hsp-hospira-second-quarter-2010-earnings-preview/44895/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MMS) MAXIMUS Incorporated &#8211; Earnings Estimates Moving Higher</title>
		<link>http://www.stockbloghub.com/2010/04/07/mms-maximus-incorporated-earnings-estimates-moving-higher/32985</link>
		<comments>http://www.stockbloghub.com/2010/04/07/mms-maximus-incorporated-earnings-estimates-moving-higher/32985#comments</comments>
		<pubDate>Wed, 07 Apr 2010 14:24:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Education & Training Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=32985</guid>
		<description><![CDATA[MAXIMUS, Inc. (MMS) has a Zacks #1 Rank and trades at 17.9x 2010 consensus EPS estimates. MAXIMUS offers investors strong growth prospects as well as some current income. Analysts expect the company to grow its earnings per share at 15% per year for the next 3 to 5 years. It also has a dividend yield of 0.8%. Company Description MAXIMUS, Inc. provides program management and consulting services to state and local government agencies, federal agencies, and commercial customers primarily in the U.S. Recent Results In early February, MAXIMUS announced fiscal first-quarter revenues of $202.4 million, up 19.2% year-over-year. The company reported earnings per share of $0.83, beating the Zacks Consensus Estimate by 19 cents, or 29.7%. In the last four quarters, MMS has beaten the Zacks Consensus Estimate by an ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/04/07/mms-maximus-incorporated-earnings-estimates-moving-higher/32985/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(STO) Statoil ASA Wades Further into US Gulf of Mexico</title>
		<link>http://www.stockbloghub.com/2010/03/18/sto-statoil-asa-wades-further-into-us-gulf-of-mexico/31094</link>
		<comments>http://www.stockbloghub.com/2010/03/18/sto-statoil-asa-wades-further-into-us-gulf-of-mexico/31094#comments</comments>
		<pubDate>Thu, 18 Mar 2010 18:03:39 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Oil & Gas Drilling & Exploration]]></category>
		<category><![CDATA[Anadarko Petroleum Corporation]]></category>
		<category><![CDATA[APC]]></category>
		<category><![CDATA[ECA]]></category>
		<category><![CDATA[Encana Corporation]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>
		<category><![CDATA[StatoilHydro ASA]]></category>
		<category><![CDATA[STO]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=31094</guid>
		<description><![CDATA[Norwegian oil major Statoil ASA (STO) yesterday said that the company was the highest bidder on 21 tracts released in Minerals Management Service&#8217;s (MMS) US Gulf of Mexico (GoM) central area lease sale. Statoil&#8217;s winning bid is, however, subject to review and final approval by MMS. Statoil aims to acquire new acreages in areas where the company already has promising exploration leads. The lease sales are important events for the company to consolidate its assets portfolio. Production growth from international operations is a key component of the company’s overall annual upstream growth plans over the next few years. The company has a growing upstream presence in the emerging basins of the Caspian Sea, West Africa and the deepwaters of the U.S. GoM. In the past, Statoil had purchased EnCana’s (ECA) ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/18/sto-statoil-asa-wades-further-into-us-gulf-of-mexico/31094/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MMS) MAXIMUS Incorporated Earnings Estimates Spike &#8211; Revenue Up 19%</title>
		<link>http://www.stockbloghub.com/2010/02/24/mms-maximus-incorporated-earnings-estimates-spike-revenue-up-19/28876</link>
		<comments>http://www.stockbloghub.com/2010/02/24/mms-maximus-incorporated-earnings-estimates-spike-revenue-up-19/28876#comments</comments>
		<pubDate>Wed, 24 Feb 2010 18:57:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Education & Training Services]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=28876</guid>
		<description><![CDATA[MAXIMUS, Inc. (MMS) shares are soaring after the latest earnings news, which included revised guidance. Company Description MAXIMUS provides government services around the world, specializing in health and human services. The company has more than 200 offices in North America, Australia, the UK and Israel. Revenue Up 19% MAXIMUS reported first quarter results for fiscal 2010 on Feb 4 that showed a 19% increase in revenue, to just over $200 million. Earnings per share came in at a record 83 cents, up from 69 cents last year. The EPS number came in 19 cents ahead of expectations, making it the fourth consecutive earnings surprise for MAXIMUS. Management also went on to raise their outlook for full-year 2010. Estimates Spike Following the earnings release, analysts raised full-year estimates. The Zacks Consensus ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/24/mms-maximus-incorporated-earnings-estimates-spike-revenue-up-19/28876/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HSP) Hospira Surges Ahead</title>
		<link>http://www.stockbloghub.com/2009/10/27/hsp-hospira-surges-ahead/18936</link>
		<comments>http://www.stockbloghub.com/2009/10/27/hsp-hospira-surges-ahead/18936#comments</comments>
		<pubDate>Wed, 28 Oct 2009 03:49:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Hospira Inc.]]></category>
		<category><![CDATA[HSP]]></category>
		<category><![CDATA[MAXIMUS Inc.]]></category>
		<category><![CDATA[MMS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=18936</guid>
		<description><![CDATA[Hospira (HSP) reported third quarter earnings of 90 cents per share, well above both the Zacks Consensus Estimate of 68 cents and 63 cents per share in the year-ago period. Revenues increased 8.9% to $1 billion, primarily driven by growth in Specialty Injectable Pharmaceuticals (SIP). SIP revenues increased 25.6% from the year-ago period (at constant exchange rates, CER) to $575.7 million while revenues from the Other Pharma segment came down 8.4% to $157.4 million. The strong growth in the SIP segment was driven by the launch of the generic oncolytic oxaliplatin in the quarter. Unlike the previous quarter, revenues from Medication Management Systems (MMS) increased 1.7% year over year at CER to $162.6 million. However, Other Devices continued to fall in the reported quarter and recorded revenues of $111.8 million, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/27/hsp-hospira-surges-ahead/18936/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

